Parkside Financial Bank & Trust’s GeneDx Holdings WGS Stock Holding History

Parkside Financial Bank & Trust’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-5	Closed	-$322	–	2801
2026 Q1	$322	Sell	5 -5	-50%	-$456	﹤0.01%	2614
2025 Q4	$1.3K	Hold	10	–	–	﹤0.01%	2251
2025 Q3	$1.08K	Buy	10 +5	+100%	+$545	﹤0.01%	2256
2025 Q2	$462	Sell	5 -5	-50%	-$393	﹤0.01%	2590
2025 Q1	$886	Buy	+10	New	+$868	﹤0.01%	2152

Other funds holding WGS

Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Parkside Financial Bank & Trust's WGS Position: Q2 2026 in Review

Parkside Financial Bank & Trust sold out of GeneDx Holdings (WGS) in Q2 2026, closing a stake of 5 shares — an estimated $322 sold.

Parkside Financial Bank & Trust first reported a position in WGS in Q1 2025 and held it in 5 quarters. The position peaked at $1.3K in Q4 2025. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

Parkside Financial Bank & Trust reported no remaining GeneDx Holdings position as of Q2 2026 after selling out during the quarter.
Parkside Financial Bank & Trust sold 5 GeneDx Holdings shares in Q2 2026, an estimated $322.
Parkside Financial Bank & Trust first reported a position in GeneDx Holdings in Q1 2025 and held it in 5 quarters.
Parkside Financial Bank & Trust's GeneDx Holdings position peaked at $1.3K in Q4 2025.
223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.